Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
1
Bullish
8
Bearish
37
Neutral
1
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Investor Presentation
Q2 FY23
Investor Presentation
Q2 FY23
Investor Presentation
Q4 FY22
Investor Presentation
Q4 FY22
Investor Presentation
Q4 FY22
Panchsheel Organics Limited is an India-based manufacturer and exporter of Active Pharmaceutical Ingredients (APIs), intermediates and finished formulations for human and veterinary use, operating multipurpose manufacturing facilities in Indore and two other units under Suneeta Chemicals and Paramount Organics. The company focuses on complex reactions across four manufacturing blocks and export-led sales.
The company reported Q1 FY2027 standalone total income of Rs. 2,518.30 lakhs and net profit of Rs. 231.20 lakhs, declaring an interim dividend of Rs. 0.80 per equity share (8%) amounting to Rs. 94.25 lakhs; earnings per share for the quarter were Rs. 1.76 and FY26 EPS was Rs. 8.22.
Operationally Q1 revenue fell sequentially by around 20.6% from Rs. 3,107.14 lakhs to Rs. 2,466.77 lakhs, while net profit rose about 36% sequentially, indicating margin resilience from lower purchases and cost control despite softer top-line during the quarter.
Significant governance changes occurred after the quarter: the company confirmed the sad demise of Managing Director Mr. Mahendra Turakhia and appointed Mr. Kishor Abhaychand Turakhia as Managing Director effective 14 August 2026, plus appointment of Mrs. Chandan Turakhia as Additional Non‑Executive Director, signalling a promoter-family succession and board reconstitution.
Pharmaceuticals & Biotechnology
Pharmaceuticals
128 Cr
High Risk
12.4
34.8
-0.5
0.9
154.40
86.10
Sales CAGR
Profit CAGR
ROE
ROCE
Panchsheel Organics Ltd (PANCHSHEEL) is currently trading at 96.60 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Panchsheel Organics Limited is an India-based manufacturer and exporter of Active Pharmaceutical Ingredients (APIs), intermediates and finished formulations for human and veterinary use, operating multipurpose manufacturing facilities in Indore and two other units under Suneeta Chemicals and Paramount Organics. The company focuses on complex reactions across four manufacturing blocks and export-led sales. The company reported Q1 FY2027 standalone total income of Rs. 2,518.30 lakhs and net profit of Rs. 231.20 lakhs, declaring an interim dividend of Rs. 0.80 per equity share (8%) amounting to Rs. 94.25 lakhs; earnings per share for the quarter were Rs. 1.76 and FY26 EPS was Rs. 8.22. Operationally Q1 revenue fell sequentially by around 20.6% from Rs. 3,107.14 lakhs to Rs. 2,466.77 lakhs, while net profit rose about 36% sequentially, indicating margin resilience from lower purchases and cost control despite softer top-line during the quarter. Significant governance changes occurred after the quarter: the company confirmed the sad demise of Managing Director Mr. Mahendra Turakhia and appointed Mr. Kishor Abhaychand Turakhia as Managing Director effective 14 August 2026, plus appointment of Mrs. Chandan Turakhia as Additional Non‑Executive Director, signalling a promoter-family succession and board reconstitution.
Over the past 52 weeks, Panchsheel Organics Ltd has traded between a low of ₹86.10 and a high of ₹154.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Panchsheel Organics Ltd has a market capitalization of approximately 127.63. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Panchsheel Organics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.39 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 127.63 Cr, Panchsheel Organics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Panchsheel Organics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Panchsheel Organics Ltd is 12.39. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Panchsheel Organics Ltd declared a final dividend of ₹0.80 per share for FY2026, announced on 30 May 2026.
The dataset states net profit fell 46.37% year-on-year to ₹1.70 crore for the quarter ending March 2026 (Q4 FY2025-26).
The company informed BSE that its Executive Whole Time Director, promoter and Managing Director, Mahendra Abhaychand Turakhia, died on August 1, 2026.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
120.50 | 132 Cr | 31.62 | 1.70 | 0.00 | 5.39 | 5.94 | 2.08 | ||
81.60 | 130 Cr | 17.92 | 1.58 | 1.47 | 7.64 | 9.18 | 1.93 | ||
111.95 | 129 Cr | 14.37 | 1.35 | 0.00 | 12.38 | 12.15 | 3.93 | ||
96.90 | 128 Cr | 12.39 | 0.91 | 3.30 | 7.69 | 9.73 | 5.99 | ||
103.43 | 127 Cr | 8.78 | 1.14 | 0.00 | 11.71 | 15.56 | 11.21 | ||
99.50 | 125 Cr | 18.05 | 2.15 | 0.00 | 9.36 | 10.75 | 3.79 | ||
141.80 | 125 Cr | 9.56 | 1.75 | 0.00 | 18.31 | 18.42 | 13.68 | ||
| Median: 7 Co. | — | 103.43 | 128 Cr | 14.37 | 1.58 | 0.00 | 9.36 | 10.75 | 3.93 |
